Hadlima (Adalimumab)
What is a Generic Drug?
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Coming Soon – Save up to 85%
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Prescription Required
-
Product Details
Description
Hadlima (adalimumab-bwwd) is an injectable medication used to treat the following:
- Rheumatoid Arthritis (RA)
- Juvenile Idiopathic Arthritis (JIA)
- Psoriatic Arthritis (PsA)
- Ankylosing Spondylitis (AS)
- Crohn’s Disease (CD)
- Ulcerative Colitis (UC)
- Plaque Psoriasis (Ps)
- Hidradenitis Suppurativa (HS)
- Uveitis (UV)
Hadlima is available as a subcutaneous injection:
- Single-dose prefilled autoinjector (HADLIMA PushTouch): 40 mg/0.8 mL
- Single-dose prefilled glass syringe: 40 mg/0.8 mL
- Single-dose prefilled autoinjector (HADLIMA PushTouch): 40 mg/0.4 mL
- Single-dose prefilled glass syringe: 40 mg/0.4 mL
Fact Table
Formula
C6428H9912N1694O1987S46
License
US FDA, EMA
Bioavailability
64% (subcutaneous)
Legal status
Prescription only
Chemical Name
Recombinant human IgG1 monoclonal antibody to TNF-a
Elimination half-life
10 to 20 days
Dosage (Strength)
40 mg/0.8 mL prefilled syringe, 40 mg/0.8 mL prefilled pen
Pregnancy
Consult a doctor
Brands
Hadlima, Humira, Amjevita, Hyrimoz, Imraldi, Abrilada, Hulio
Protein binding
Not significantly protein bound
PubChem CID
24826798
MedlinePlus
a602011
ChEBI
CHEBI:134722
ATC code
L04AB04
DrugBank
DB00051
KEGG
D03136
Routes of administration
Subcutaneous
Directions
Use Hadlima exactly as the prescribing doctor has directed.
The doctor will determine an appropriate treatment regimen for you or your child based weight and the condition being treated.
The first injection should be administered under the supervision of a qualified healthcare professional, who will teach you or a caregiver how to properly store, prepare, administer, and discard Hadlima.
Medication products, needles, and syringes should not be shared with other people.
For further instructions for use, you may refer to the medication guide that comes with the Hadlima prescription.
Talk to your doctor or pharmacist about any questions or concerns you have.
Ingredients
The active ingredient in Hadlima is adalimumab-bwwd.
Contraindications
There are no contraindications listed according to the most recent Prescribing Information.
Cautions
- Hadlima contains the following FDA Boxed Warning:
“SERIOUS INFECTIONS: Increased risk of serious infections leading to hospitalization
or death, including tuberculosis (TB), bacterial sepsis,
invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens.
Discontinue Hadlima if a patient develops a serious infection or sepsis during treatment.
Perform test for latent TB; if positive, start treatment for TB prior to starting Hadlima.
Monitor all patients for active TB during treatment, even if the initial latent TB test is negative.
MALIGNANCY: Lymphoma and other malignancies, some fatal, have been
reported in children and adolescent patients treated with TNF blockers including adalimumab products.
Post-marketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have occurred in adolescent and young adults with inflammatory bowel disease treated with TNF blockers including adalimumab products.”
- Before you or your child begins treatment with Hadlima, talk to the prescribing doctor about:
- All the prescription and over-the-counter medications you or your child takes
- You or your child’s allergies
- You or your child’s current health problems and past medical history
- You or your child’s pregnancy or breastfeeding status
- Hadlima contains the following warnings and precautions:
- Infections that are serious
- Fungal infections that are invasive
- Malignancies
- Serious hypersensitivity reactions, including anaphylaxis
- Hepatitis B virus reactivation
- Demyelinating disease
- Cytopenias and pancytopenia (low blood cell counts)
- Worsening or new heart failure
- Lupus-like syndrome
Side Effects
Infections, injection site reactions, rash, and headache are some Hadlima side effects; however, other side effects may also occur.
Contact a doctor right away if you or your child has side effects that are bothersome or won’t go away.
Searching for a Hadlima cost that’s competitive? With a valid prescription, you can buy Hadlima right here!
Reference
Hadlima. Jersey City, NJ: Organon & Co.; 2024.
IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.Product Code : 14373
-
Product Reviews
